change from semaglutide to tirzepatide Switching dose conversion Semaglutide vs. Tirzepatide for Obesity

Patient education on recognizing signs of adverse reactions and the significance of adhering to recommended dosages cannot be overstated

It is important to understand whether the cardiovascular benefits of GLP-1RAs are limited to those who also experience glycemic and/or weight benefits, or we see benefits in hard outcomes more broadly

Sources Hair And Stress: A Pilot Study Of Hair And Cytokine Balance Alteration In Healthy Young Women Under Major Exam Stress (April 19, 2017) Telogen Effluvium (May 1, 2024) Tirzepatide Once Weekly for the Treatment of Obesity (June 4, 2022) Dietary Vitamin A Impacts Refractory Telogen (February 04, 2021) Vitamin A and Carotenoids (March 10, 2025) A Randomized, Placebo-controlled Clinical Study Evaluating a Dietary Supplement for Hair Growth (2024) Role of vitamin D in hair loss: A short review (September 22, 2021) Vitamin D: Fact Sheet for Consumers (November 8, 2022) A Review Of The Growing Risk Of Vitamin D Toxicity From Inappropriate Practice (March 02, 2018) The diagnosis and treatment of iron deficiency and its potential relationship to hair loss (May 2006) Serum Zinc Concentration in Patients with Alopecia Areata (October 03, 2023) Zinc: Fact Sheet for Health Professionals (September 28, 2022) Diet And Hair Loss: Effects Of Nutrient Deficiency And Supplement Use (January 31, 2017) Improvement In Scalp Hair Growth In Androgen-Deficient Women Treated With Testosterone: A Questionnaire Study (February 2012) Is Thyroid Dysfunction A Common Cause Of Telogen Effluvium?: A Retrospective Study (January 05, 2024) Patterned Loss Of Hair In Man

doi: 10.1016/j.jaad.2018.12.020 22 ChanTAYarchoanMJafeeESwantonCQuezadaSAStenzingerAet al